Claventin and cardiac failure congestive Patient Reports February 13, 2012



Claventin Side Effects Report #5075823-9
Claventin side effect was reported by a Consumer or non-health professional from FRANCE on Aug 03, 2006. Female patient, 57 years of age, was treated with Claventin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cardiac failure congestive, hepatocellular damage, hyperkalaemia, prothrombin level decreased, respiratory distress. Claventin dosage: unknown. During the same period patient was treated with IMUREL. Patient was hospitalized. Patient recovered.

Claventin Side Effects Report #5168230-1
Claventin side effect was reported by a Consumer or non-health professional from FRANCE on Aug 03, 2006. Female patient, 57 years of age, was treated with Claventin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, cardiac failure congestive, hepatic failure, hepatocellular damage, hyperkalaemia, prothrombin level decreased. Claventin dosage: unknown. During the same period patient was treated with IMUREL. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Claventin